De co- primære endpoints var forholdet af patienter i klinisk remission (CDAI < 150) ved uge 30 og tiden til tab af respons efter uge 54.
The co-primary endpoints were the proportion of patients in clinical remission (CDAI < 150) at week 30 and time to loss of response through week 54.